Script: compare_isoforms.py (standard library; fetches sequences from UniProt REST).
Raw output: compare_isoforms_output.txt.
All four blue whale UniProt entries for CDK16 come from one gene (NCBI GeneID 118888515,
chromosome X) and differ only at their N termini (RefSeq XP_036695535-XP_036695538).
Residues mapped onto A0A8B8WEG2:
| human CDK16 residue | role (literature) | A0A8B8WEG2 |
|---|---|---|
| Ser12 | BRSK2 phosphosite | absent |
| Ser95 | CDK5 phosphosite | S20 |
| 112-121 | conserved segment required for CCNY binding | present (from E37) |
| Ser119 | needed for CCNY binding | S44 |
| Ser153 | PKA site; phosphorylation blocks CCNY binding | S78 |
| Gly158 | needed for CCNY binding | G83 |
| Lys194 | catalytic lysine | K119 |
| Asp286 | catalytic proton acceptor | D211 |
| 461-473 | C-terminal segment needed for CCNY binding | present (from S386) |
A0A8B8WEG2 is an N-terminally shorter alternative-start isoform, not a fragment. It keeps the
complete kinase domain, the catalytic residues and all the cyclin Y binding determinants mapped by
Mikolcevic et al. 2012, who reported that the first 105 residues of CDK16 are not needed for CCNY
binding. Its only loss among the mapped sites is the N-terminal Ser12 BRSK2 phosphosite.